TrialThe Journal of clinical endocrinology and metabolism2022

Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia.

Afroze Abbas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.